| Name | (Z)-methyl 3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxybiphenyl-3-carboxylate |
|---|---|
| Synonyms |
Methyl 3'-{(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-3-biphenylcarboxylate
Eltrombopag Methyl Ester [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, methyl ester |
| Description | Eltrombopag methyl ester is a derivative of Eltrombopag, which is a thrombopoietin (Tpo) receptor agonist, which can promote platelet production and is used in research related to specific types of thrombocytopenia[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof. WO2010114943. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 626.5±65.0 °C at 760 mmHg |
| Molecular Formula | C26H24N4O4 |
| Molecular Weight | 456.49 |
| Flash Point | 332.7±34.3 °C |
| Exact Mass | 456.179749 |
| PSA | 103.59000 |
| LogP | 3.82 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.641 |